Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

4.14
Delayed Data
As of Jul 25
 +0.07 / +1.72%
Today’s Change
3.34
Today|||52-Week Range
8.79
-40.26%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close4.07
Today’s open4.18
Day’s range4.09 - 4.26
Volume68,898
Average volume (3 months)41,896
Market cap$54.2M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+43.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.02-4.48%
CATBCatabasis Pharmaceut...+0.10+2.68%
EBIOEleven Biotherapeuti...+0.39+14.50%
SCYXSCYNEXIS Inc-0.15-6.55%
Data as of 07/25/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs